| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Alendronate | FAERS: 7 | US FAERS | |
| 2 | Finasteride | FAERS: 2 | US FAERS | |
| 3 | NuvaRing | FAERS: 2 | US FAERS | |
| 4 | telotristat ethyl | FAERS: 2 | US FAERS | |
| 5 | venetoclax | FAERS: 2 | US FAERS | |
| 6 | Baclofen | FAERS: 1 | US FAERS | |
| 7 | Sevelamer | FAERS: 1 | US FAERS | |
| 8 | niraparib | FAERS: 1 | US FAERS | |
| 9 | Aspirin-oxycodone hydrochloride-oxycodone terephthalate combination | SIDER | ||
| 10 | Chlordiazepoxide | OFFSIDES | ||
| 11 | PCI 32765 | Canada Vigilance: 1 | Canada Vigilance | |
| 12 | Raloxifene Hydrochloride | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.